Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation vs No Sedation in Mechanically Ventilated COPD Patients
NCT07620912Phase 2Completed
- Sponsor
- Al-Azhar University
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of midazolam in chronic obstructive pulmonary disease (COPD) and respiratory failure (2 arms), sponsored by Al-Azhar University. Primary endpoint: Ventilator-free days at 28 days. Started Apr 2025; status: completed.
02
Drugs
midazolam
03
Conditions
chronic obstructive pulmonary disease (COPD)respiratory failure
Beyond the preview
Go deeper on NCT07620912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07620912.